» Articles » PMID: 39385213

Mechanisms of Neural Infiltration-mediated Tumor Metabolic Reprogramming Impacting Immunotherapy Efficacy in Non-small Cell Lung Cancer

Overview
Publisher Biomed Central
Specialty Oncology
Date 2024 Oct 10
PMID 39385213
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Current evidence underlines the active role of neural infiltration and axonogenesis within the tumor microenvironment (TME), with implications for tumor progression. Infiltrating nerves stimulate tumor growth and dissemination by secreting neurotransmitters, whereas tumor cells influence nerve growth and differentiation through complex interactions, promoting tumor progression. However, the role of neural infiltration in the progression of non-small cell lung cancer (NSCLC) remains unclear.

Methods: This study employs the techniques of immunohistochemistry, immunofluorescence, RNA sequencing, molecular biology experiments, and a murine orthotopic lung cancer model to deeply analyze the specific mechanisms behind the differential efficacy of NSCLC immunotherapy from the perspectives of neuro-tumor signal transduction, tumor metabolism, and tumor immunity.

Results: This study demonstrates that nerve growth factor (NGF) drives neural infiltration in NSCLC, and 5-hydroxytryptamine (5-HT), which is secreted by nerves, is significantly elevated in tumors with extensive neural infiltration. Transcriptome sequencing revealed that 5-HT enhanced glycolysis in NSCLC cells. Pathway analysis indicated that 5-HT activated the PI3K/Akt/mTOR pathway, promoting tumor metabolic reprogramming. This reprogramming exacerbated immunosuppression in the TME. Neutralizing 5-HT-mediated metabolic reprogramming in tumor immunity enhanced the efficacy of PD-1 monoclonal antibody treatment in mice.

Conclusions: The findings of this study provide a novel perspective on the crosstalk between nerves and lung cancer cells and provide insights into further investigations into the role of nerve infiltration in NSCLC progression.

Citing Articles

Hijacking of the nervous system in cancer: mechanism and therapeutic targets.

Zhang Y, Liao Q, Wen X, Fan J, Yuan T, Tong X Mol Cancer. 2025; 24(1):44.

PMID: 39915765 PMC: 11800603. DOI: 10.1186/s12943-025-02246-5.


Revisiting of Cancer Immunotherapy: Insight from the Dialogue between Glycolysis and PD-1/PD-L1 Axis in the Tumor Microenvironment.

Liu Q, Liu Z, Zhang X, Zeng A, Song L Int J Biol Sci. 2025; 21(3):1202-1221.

PMID: 39897050 PMC: 11781164. DOI: 10.7150/ijbs.104079.

References
1.
Hanoun M, Maryanovich M, Arnal-Estape A, Frenette P . Neural regulation of hematopoiesis, inflammation, and cancer. Neuron. 2015; 86(2):360-73. PMC: 4416657. DOI: 10.1016/j.neuron.2015.01.026. View

2.
Duvel K, Yecies J, Menon S, Raman P, Lipovsky A, Souza A . Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010; 39(2):171-83. PMC: 2946786. DOI: 10.1016/j.molcel.2010.06.022. View

3.
Cheng S, Quintin J, Cramer R, Shepardson K, Saeed S, Kumar V . mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014; 345(6204):1250684. PMC: 4226238. DOI: 10.1126/science.1250684. View

4.
Boilly B, Faulkner S, Jobling P, Hondermarck H . Nerve Dependence: From Regeneration to Cancer. Cancer Cell. 2017; 31(3):342-354. DOI: 10.1016/j.ccell.2017.02.005. View

5.
Marchesi F, Piemonti L, Mantovani A, Allavena P . Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev. 2010; 21(1):77-82. DOI: 10.1016/j.cytogfr.2009.11.001. View